Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Gangemi, Rosaria ^a   Mirisola, Valentina ^a   Barisione, Gaia ^a   Fabbi, Marina ^a   Brizzolara, Antonella ^a   Lanza, Francesco ^b   Mosci, Carlo ^b   Salvi, Sandra ^a   Gualco, Marina ^a   Truini, Mauro ^a   Angelini, Giovanna ^a   Boccardo, Simona ^a   Cilli, Michele ^a   Airoldi, Irma ^c   Queirolo, Paola ^a   Jager, Martine J ^d   Daga, Antonio ^a   Pfeffer, Ulrich ^a   Ferrini, Silvano ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b GALLIERA HOSPITAL   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR GAMMA; SCATTER FACTOR; SMALL INTERFERING RNA; SYNTENIN; MESSENGER RNA; SDCBP PROTEIN, HUMAN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CELL CULTURE; CELL MIGRATION; CHROMOSOME 8; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOPLASM; DISEASE FREE SURVIVAL; EYE BIOPSY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MALE; METASTASIS POTENTIAL; MONOSOMY; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR RECURRENCE; UVEA MELANOMA; WOUND HEALING; ANIMAL; CELL MOTION; DISEASE COURSE; DRUG SCREENING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; LIVER TUMOR; MELANOMA; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UVEA TUMOR;

MUS;

AGED; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MELANOMA; MICE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SYNTENINS; UVEAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84855838685     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029989     Document Type: Article

References (42)

1. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM, (1988) Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 32: 239-251.
2. Singh AD, Bergman L, Seregard S, (2005) Uveal melanoma: epidemiologic aspects. Ophthalmol Clin North Am 18: 75-84.
3. Cree IA, (2000) Cell cycle and melanoma-two different tumors from the same cell type. J Pathol 191: 112-114.
4. Damato B, (2010) Does ocular treatment of uveal melanoma influence survival? Br J Cancer 103: 285-290 Review.
5. Mallikarjuna K, Pushparaj V, Biswas J, Krishnakumar S, (2007) Expression of epidermal growth factor receptor, ezrin,hepatocyte growth factor, and c-MET in uveal melanoma: an immunohistochemical study. Curr Eye Res 32: 281-290.
6. Di Cesare S, Marshall JC, Logan P, Antecka E, Faingold D, et al. (2007) Expression and migratory analysis of 5 human uveal melanoma cell lines for CXCL12, CXCL8, CXCL1, and HGF. J Carcinog 6: 2.
7. Peruzzi B, Bottaro DP, (2006) Targeting the c-MET signaling pathway in cancer. Clin Cancer Res 12: 3657-3660.
8. All-Ericsson C, Girnita L, Seregard S, Bartolazzi A, Jager MJ, et al. (2002) Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target. Invest Ophthalmol Vis Sci 43: 1-8.
9. Mouriaux F, Kherrouche Z, Maurage CA, Demailly FX, Labalette P, et al. (2003) Expression of the c-Kit receptor in choroidal melanomas. Melanoma Res 13: 161-166.
10. Mouriaux F, Chahud F, Maurage CA, Malecaze F, Labalette P, (2001) Implication of stem cell factor in the proliferation of choroidal melanocytes. Exp Eye Res 73: 151-157.
11. Lefevre G, Glotin AL, Calipel A, Mouriaux F, Tran T, et al. (2004) Role of stem cell factor/c-Kit and effects of Glivec/STI571 in human uveal melanoma cell tumorigenesis. J Biol Chem 279: 31769-1779.
12. Li H, Yang W, Chen PW, Alizadeh H, Niederkorn JY, (2009) Inhibition of chemokine receptor expression on uveal melanomas by CXCR4 siRNA and its effect on uveal melanoma liver metastases. Invest Ophthalmol Vis Sci 50: 5522-8.
13. Onken WD, Worley LA, Ehlers JP, Harbour JW, (2004) Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 64: 7205-7209.
14. Onken MD, Ehlers JP, Worley LA, Makita J, Yokota Y, et al. (2006) Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Res 66: 4602-4609.
15. Agapova OA, Person E, Harbour JW, (2010) Id2 deficiency promotes metastasis in a mouse model of ocular cancer. Clin Exp Metastasis 27: 91-96.
16. Onken MD, Worley LA, Tuscan MD, Harbour JW, (2010) An Accurate, Clinically Feasible Multi-Gene Expression Assay for Predicting Metastasis in Uveal Melanoma. J Mol Diagn 12: 461-468.
17. Lin JJ, Jiang H, Fisher PB, (1998) Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene. Gene 207: 105-110.
18. Sarkar D, Boukerche H, Su ZZ, Fisher PB, (2004) mda-9/syntenin: recent insights into a novel cell signaling and metastasis-associated gene. Pharmacol Ther 104: 101-115 Review.
19. Boukerche H, Su ZZ, Emdad L, Baril P, Balme B, et al. (2005) mda-9/Syntenin: a positive regulator of melanoma metastasis. Cancer Res 65: 10901-10911.
20. Zimmermann P, Meerschaert K, Reekmans G, Leenaerts I, Small JV, et al. (2002) PIP(2)-PDZ domain binding controls the association of syntenin with the plasma membrane. Mol Cell 9: 1215-1225.
21. Zimmermann P, Zhang Z, Degeest G, Mortier E, Leenaerts I, et al. (2005) Syndecan recycling is controlled by syntenin-PIP2 interaction and Arf 6. Dev cell 9: 377-388.
22. Estrach S, Legg J, Watt FM, (2007) Syntenin mediates Delta1-induced cohesiveness of epidermal stem cells in culture. J Cell Sci 120: 2944-2952.
23. Beekman JM, Coffer PJ, (2008) The ins and outs of syntenin, a multifunctional intracellular adaptor protein. Cell Sci 121: 1349-1355.
24. Geijsen N, Uings IJ, Pals C, Armstrong J, McKinnon M, et al. (2001) Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein. Science 293: 1136-1138.
25. Helmke BM, Polychronidis M, Benner A, Thome M, Arribas J, et al. (2004) Melanoma metastasis is associated with enhanced expression of the syntenin gene. Oncol Rep 12: 221-228.
26. Boukerche H, Su ZZ, Emdad L, Fisher PB, (2007) mda-9/syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kB. Cancer Res 67: 1812-1822.
27. Koo TH, Lee JJ, Kim EM, Kim KW, Kim HD, et al. (2002) Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines. Oncogene 21: 4080-4088.
28. Boukerche H, Su ZZ, Prévot C, Sarkar D, Fisher PB, (2008) mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src. Proc Natl Acad Sci U S A 105: 15914-1599.
29. Boukerche H, Aissaoui H, Prévost C, Hirbec H, Das SK, et al. (2010) Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB. Oncogene 29: 3054-3066.
30. De Waard-Siebinga I, Blom DJ, Griffioen M, Schrier PI, Hoogendoorn E, et al. (1995) Establishment and characterization of an uveal-melanoma cell line. Int J Cancer 62: 155-161.
31. Verbik DJ, Murray TG, Tran JM, Ksander BR, (1997) Melanomas that develop within the eye inhibit lymphocyte proliferation. Int J Cancer 14: 470-478.
32. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31 (4): e15.
33. Chatterjee N, Stegmüller J, Schätzle P, Karram K, Koroll M, et al. (2008) Interaction of SDCBP and the NG2 proteoglycan in migratory oligodendrocyte precursor cells. J Biol Chem 283: 8310-8317.
34. Mirisola V, Zuccarino A, Bachmeier BE, Sormani MP, Falter J, et al. (2009) CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival U. Eur J Cancer 45: 2579-2587.
35. Laurent C, Valet F, Planque N, Silveri L, Maacha S, et al. (2011) High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients. Cancer Res 71: 666-67436.
36. Ma D, Luyten GP, Luider TM, Niederkorn JY, (1995) Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Invest Ophthalmol Vis Sci 36: 435-441.
37. Dewan MZ, Terunuma H, Ahmed S, Ohba K, Takada M, et al. (2005) Natural killer cells in breast cancer cell growth and metastasis in SCID mice. Biomed Pharmacother 59 (Suppl 2): 375-379 Review.
38. Giannoni P, Scaglione S, Quarto R, Narcisi R, Parodi M, et al. (2011) An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease. Haematologica 96: 1015-1023.
39. Chen SY, Chen HC, (2006) Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion. Mol Cell Biol 26: 5155-67.
40. Beekman JM, Vervoort SJ, Dekkers F, van Vessem ME, Vendelbosch S, et al. (2011) Syntenin-mediated regulation of Sox4 proteasomal degradation modulates transcriptional output. Oncogene doi:10.1038/onc.2011.445.
41. Gentile A, Trusolino L, Comoglio PM, (2008) The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev pp. 85-94 Review.
42. Ye M, Hu D, Tu L, Zhou X, Lu F, et al. (2008) Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells. Invest Ophthalmol Vis Sci 49: 497-504.